Elmiron is used to treat a “painful bladder syndrome”, known as interstitial cystitis. It is prescribed for osteoarthritis in human as well as elderly horses and dogs. Once, Elmiron was also used as an anti-coagulant. However, the issue that many people face with using Elmiron is that many a time its long-term exposure has led to maculopathy. Maculopathy is an eye-disorder that affects the central part of the retina i.e. the macula and is a major cause of blindness. And blindness can be said to be another name for lifelong grief.
If you or your loved one has been affected with blindness as a result of using Elmiron, contact a Pittsburgh Elmiron lawyer at the Logue Law Group. We are an experienced group of lawyers that assure you the deserved compensation for your loss. We have been handling Elmiron lawsuits for many years are certainly one of the best Law Groups in the United States.Facts About the Elmiron-Caused Maculopathy
The American Academy of Ophthalmology in 2018 published an article which spoke about six patients (treated at the Emory Eye Center between 2015 and 2017).These patients had pigmentary maculopathy following a chronic exposure to Elmiron for interstitial cystitis. In 2019, an update followed stating that ten more patients had been diagnosed with the same issue at Emory Eye Center.Types of Maculopathy Resulting From Elmiron
Maculopathy is an umbrella for all the pathological conditions that may affect the macula of the eye. The visual sensitivity and acuity depends on the macula.
The different types of Maculopathy include:
- Macular Degeneration (age-related): A degenerative eye condition that develops with time. There is gradual sight loss, beginning from the central field of vision.
- Cellophane Maculopathy: It causes a distortion in viewing that is a result of a pull generated on the nerve cells (light-receptive) of the macula by a transparent thin layer of scar tissue that forms over time. This condition is also called “macular pucker.”
- Malattia Leventinese: An inherited form of macular degeneration; It begins with pale,small spots in the macula. Then with time, they eventually grow into a pattern resembling a honeycomb. Also called Doyne Honeycomb Retinal Dystrophy (DHRD).
As for the type of macular de-generation that is linked with Elmiron, “Pigmentary Maculopathy of Unknown Etiology” is the name for it; a macular injury without a known cause. The condition’s presentation differs from one patient to another, although slightly, but its symptoms include one, some or all of the following:
- Parafoveal pigmented deposits: Abnormal behavior of the blood vessels and capillaries around the macula, causing vision loss.
- Vitelli form deposits: Also known as “adult pattern macular dystrophy”, these are yellowish, round lesions which form underneath the macula.
- Retinal Pigment Epithelium Atrophy: A common age-related symptom of macular-degeneration.
- There are also patients with hyper-pigmented (darkened spots) on the retina found during an eye examination.
For any such kind of condition, contacting a Pittsburgh Elmiron Lawsuit Lawyer of the Logue Law Group will help you get the compensation you deserve and gain some stability back in your life, or of the one affected.Other Damages Caused by Elmiron
Other than the ones mentioned above, there are other side effects that patients prescribed with Elmiron have reported. These include:
- Alopecia (hair loss)
- Gastroesophageal reflux
- Sleep disorders
- Skin rash
- Elmiron Warnings
In any case, our experienced Pittsburgh Elmiron lawyer can legally help you get the rightful compensation you deserve.Warnings About Elmiron and Maculopathy
Between 1997 and 2019, the FDA Adverse Event Reporting System (FAERS) had 100 cases filed which were “eye disorders” among Elmiron patients. Among these, 80 were classified as “serious”. More than 22 reports mentioned maculopathy of some form or the other.
The product labeling of Elmirondoes not describeany form of maculopathy. However, within the Adverse Reactions section, there are references to vision-related disorders like conjunctivitis, nystagmus, amblyopia, optic neuritis and retinal hemorrhage as observed in pre-market clinical trials. The labeling has no relevant warnings, and neither does it identify adverse events related to it as observed in the post-marketing setting.Get in Touch With Pittsburgh Elmiron Lawsuit Lawyer
If you or your loved one has been affected with partial or complete blindness or any of the above-mentioned complications as a result of Elmiron, contact the Logue Law Group. Our Pittsburgh Elmiron Lawsuit lawyer will ensure you get as much stability as possible back in your life. We at Logue Law Group understand the intricacies of an Elmiron claim and will ensure you get justice. Give us a call today for free consultation.